Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Chromadex Corp CS (CDXC)

Chromadex Corp CS (CDXC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 699,031
  • Shares Outstanding, K 67,933
  • Annual Sales, $ 59,260 K
  • Annual Income, $ -19,930 K
  • 60-Month Beta 1.68
  • Price/Sales 11.50
  • Price/Cash Flow N/A
  • Price/Book 15.55
Trade CDXC with:

Options Overview

Details
  • Implied Volatility 85.76%
  • Historical Volatility 56.80%
  • IV Percentile 29%
  • IV Rank 17.34%
  • IV High 302.83% on 02/26/21
  • IV Low 40.22% on 06/16/20
  • Put/Call Vol Ratio 0.10
  • Today's Volume 913
  • Volume Avg (30-Day) 888
  • Put/Call OI Ratio 0.27
  • Today's Open Interest 28,281
  • Open Int (30-Day) 34,122

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.09
  • Number of Estimates 3
  • High Estimate -0.07
  • Low Estimate -0.11
  • Prior Year -0.06
  • Growth Rate Est. (year over year) -50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.55 +57.10%
on 05/13/21
10.78 -4.55%
on 06/11/21
+3.21 (+45.34%)
since 05/11/21
3-Month
6.55 +57.10%
on 05/13/21
14.45 -28.79%
on 03/16/21
-1.02 (-9.02%)
since 03/11/21
52-Week
3.82 +169.37%
on 10/02/20
23.66 -56.51%
on 02/25/21
+6.15 (+148.55%)
since 06/11/20

Most Recent Stories

More News
ChromaDex and Walmart Launch Tru Niagen(R) in 3,800 Walmart Stores Across the United States

ChromaDex Corp. (NASDAQ:CDXC) announced today the launch of its flagship consumer product Tru Niagen(R) in Walmart, available in 3,800 stores across the United States. Walmart is the first major U.S. retailer...

CDXC : 10.29 (+2.59%)
ChromaDex (CDXC) Reports Q1 Loss, Misses Revenue Estimates

ChromaDex (CDXC) delivered earnings and revenue surprises of -33.33% and -10.87%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

CDXC : 10.29 (+2.59%)
ChromaDex Corporation Reports First Quarter 2021 Financial Results

ChromaDex Corp. (NASDAQ:CDXC) today reported first quarter 2021 financial results.

CDXC : 10.29 (+2.59%)
Chromadex Corp. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 6, 2021 / Chromadex Corp. (NASDAQ:CDXC) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 6, 2021 at 4:30 PM Eastern...

CDXC : 10.29 (+2.59%)
ChromaDex and Ro Partner for New Product Development

ChromaDex Corp. (NASDAQ:CDXC) announced today that it entered into a strategic supply agreement for Niagen(R) with Ro, a healthcare-technology company. The agreement provides Ro with rights to ChromaDex's...

CDXC : 10.29 (+2.59%)
ChromaDex to Present at Benzinga's Global Small Cap Conference on May 13, 2021

ChromaDex Corp. (NASDAQ: CDXC) is scheduled to participate in a virtual presentation at the Benzinga Small Cap Conference on Thursday, May 13, 2021 at 11:30am ET (8:30am PT). ChromaDex CEO, Rob Fried,...

CDXC : 10.29 (+2.59%)
ChromaDex to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021

ChromaDex Corp. (NASDAQ:CDXC) announced that it will hold a conference call on Thurs., May 6, 2021 at 4:30 p.m. ET to discuss its financial results for the first quarter ended March 31, 2021. The financial...

CDXC : 10.29 (+2.59%)
ChromaDex and Health & Happiness (H&H) Group Announce Supply Agreement for Niagen(R)

ChromaDex Corp. (NASDAQ:CDXC) announced today it entered into a strategic supply agreement with Health & Happiness (H&H) Group, a global leader in premium health, human and pet nutrition and personal care...

CDXC : 10.29 (+2.59%)
ChromaDex Appoints Fadi Karam as Chief Marketing Officer

ChromaDex Corp. (NASDAQ:CDXC) announced today that it has appointed Fadi Karam as Chief Marketing Officer.

CDXC : 10.29 (+2.59%)
ChromaDex and the Citrin Foundation Announce Global Research Collaboration Exploring Citrin Deficiency

ChromaDex Corp. (NASDAQ: CDXC) today announced a new research initiative with the Citrin Foundation of Singapore to study the effects of Niagen(R) nicotinamide riboside (NR) and citrin deficiency, a rare...

CDXC : 10.29 (+2.59%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

ChromaDex Corporation and its subsidiaries supply phytochemical reference standards and reference materials, related contract services, and products for the dietary supplement, nutraceutical, food and beverage, functional food, pharmaceutical and cosmetic markets. ChromaDex's core business strategy is...

See More

Key Turning Points

3rd Resistance Point 11.31
2nd Resistance Point 11.04
1st Resistance Point 10.67
Last Price 10.29
1st Support Level 10.03
2nd Support Level 9.76
3rd Support Level 9.39

See More

52-Week High 23.66
Fibonacci 61.8% 16.08
Fibonacci 50% 13.74
Fibonacci 38.2% 11.40
Last Price 10.29
52-Week Low 3.82

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar